Dr Mark Robert Windt, MD in North Hampton, NH - Medicare Pulmonary Disease

Dr Mark Robert Windt, MD is a medicare enrolled "Allergy & Immunology" physician in North Hampton, New Hampshire. He went to University Of Connecticut School Of Medicine and graduated in 1978 and has 46 years of diverse experience with area of expertise as Pulmonary Disease. His current practice location is 65 Lafayette Rd, Second Floor, North Hampton, New Hampshire. You can reach out to his office (for appointments etc.) via phone at (603) 964-3392.

Dr Mark Robert Windt is licensed to practice in New Hampshire (license number 7208) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1689625600.

Contact Information

	Dr Mark Robert Windt, MD
	65 Lafayette Rd, Second Floor, North Hampton, NH 03862-2480
	(603) 964-3392
	(603) 964-3396

Physician's Profile

Full Name	Dr Mark Robert Windt
Gender	Male
Speciality	Pulmonary Disease
Experience	46 Years
Location	65 Lafayette Rd, North Hampton, New Hampshire
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Mark Robert Windt attended and graduated from University Of Connecticut School Of Medicine in 1978

NPI Data:

NPI Number: 1689625600
Provider Enumeration Date: 05/15/2006
Last Update Date: 07/09/2007

Medicare PECOS Information:

PECOS PAC ID: 5890752471
Enrollment ID: I20060508000850

Medical Identifiers

Medical identifiers for Dr Mark Robert Windt such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1689625600	NPI	-	NPPES
30008459	Medicaid	NH

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207K00000X	Allergy & Immunology	7208 (New Hampshire)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Portsmouth Regional Hospital	Portsmouth, NH	Hospital
York Hospital	York, ME	Hospital

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Mark Robert Windt is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Mark Robert Windt, MD 65 Lafayette Rd, Second Floor, North Hampton, NH 03862-2480 Ph: (603) 964-3392	Dr Mark Robert Windt, MD 65 Lafayette Rd, Second Floor, North Hampton, NH 03862-2480 Ph: (603) 964-3392

News Archive

Magnus Medical receives FDA's Breakthrough Device Designation for rapid-acting technology to treat major depression

Magnus Medical, Inc., a medical device company, today announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device Designation for its individualized, rapid-acting, non-invasive neurostimulation technology designed to treat major depressive disorder (MDD) in people who have not improved sufficiently from antidepressant medication or other treatments.

Study shows chronic diseases have strong negative impact on cancer survival rate

There are many people in this position and the number is increasing; cancer patients who not only have to fight against cancer, but also suffer from other diseases. So-called comorbidity is a large and growing problem, not least because we are becoming older and age increases the risk of contracting cancer as well as other diseases.

Continuous personnel changes are a major cause of NHS ultrasound staff shortage, shows study

A new study of ultrasound departments shows that continuous personnel changes are a major cause of the now serious shortage of ultrasound staff in the NHS.

LSU Health New Orleans receives $10 million grant to support research on virus-induced cancers

The National Institute of General Medical Sciences has awarded LSU Health New Orleans a $10 million grant over five years to support new basic research studies advancing the development new diagnostic and therapeutic approaches for virus-induced cancers.

Scientists show promising results for new treatment approach in follicular lymphoma

A study led by Manchester scientists has shown promising results for a new treatment approach in follicular lymphoma. Follicular lymphoma is a type of non-Hodgkin's lymphoma- a blood cancer - that usually develops slowly. The majority of patients are diagnosed when their disease is at an advanced stage.

Dr Mark Robert Windt, MD - Medicare Pulmonary Disease in North Hampton, NH